Comments on: Efficacy and safety of odevixibat in patients with alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

Comments on: Efficacy and safety of odevixibat in patients with alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial https://childliverdisease.org/efficacy-and-safety-of-odevixibat-in-patients-with-alagille-syndrome-assert-a-phase-3-double-blind-randomised-placebo-controlled-trial/?utm_source=rss&utm_medium=rss&utm_campaign=efficacy-and-safety-of-odevixibat-in-patients-with-alagille-syndrome-assert-a-phase-3-double-blind-randomised-placebo-controlled-trial Just another WordPress site Mon, 17 Jun 2024 15:53:56 +0000 hourly 1 https://wordpress.org/?v=6.9.4